ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,354.05
0.49%
Dow Jones
38,954.65
0.18%
Gold vs US Dollar
2,314.73
-0.01%
Brent Oil
83.175
0.37%
Bitcoin
62,582.89
0.40%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Cara Therapeutics Inc (CARA)

  7. Cara Therapeutics Inc (CARA) News

Cara Therapeutics (CARA)

Cara Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CARA
DateTimeSourceHeadlineSymbolCompany
06/05/202421:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CARACara Therapeutics Inc
06/05/202412:00GlobeNewswire Inc.Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024NASDAQ:CARACara Therapeutics Inc
02/04/202412:00GlobeNewswire Inc.Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:CARACara Therapeutics Inc
07/03/202412:00GlobeNewswire Inc.Cara Therapeutics to Host Notalgia Paresthetica (NP) Virtual KOL Event on Wednesday, March 27, 2024NASDAQ:CARACara Therapeutics Inc
06/03/202421:45Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CARACara Therapeutics Inc
04/03/202421:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CARACara Therapeutics Inc
04/03/202421:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CARACara Therapeutics Inc
04/03/202421:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CARACara Therapeutics Inc
04/03/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CARACara Therapeutics Inc
04/03/202421:01GlobeNewswire Inc.Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:CARACara Therapeutics Inc
13/02/202423:50Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CARACara Therapeutics Inc
12/02/202422:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CARACara Therapeutics Inc
12/02/202422:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CARACara Therapeutics Inc
12/02/202422:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CARACara Therapeutics Inc
12/02/202422:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CARACara Therapeutics Inc
12/02/202421:01GlobeNewswire Inc.Cara Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024NASDAQ:CARACara Therapeutics Inc
05/02/202421:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CARACara Therapeutics Inc
05/02/202421:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CARACara Therapeutics Inc
05/02/202421:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CARACara Therapeutics Inc
05/02/202421:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CARACara Therapeutics Inc
05/02/202421:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CARACara Therapeutics Inc
02/02/202421:59Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CARACara Therapeutics Inc
29/01/202420:26Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CARACara Therapeutics Inc
22/01/202421:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CARACara Therapeutics Inc
22/01/202412:00GlobeNewswire Inc.Cara Therapeutics Prioritizes Late-Stage Notalgia Paresthetica Program and Extends Cash Runway into 2026NASDAQ:CARACara Therapeutics Inc
18/12/202312:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CARACara Therapeutics Inc
18/12/202312:00GlobeNewswire Inc.Cara Therapeutics Announces Outcome from Dose-Finding Part A of KIND 1 Study Evaluating Oral Difelikefalin for Moderate-to-Severe Pruritus in Patients with Atopic DermatitisNASDAQ:CARACara Therapeutics Inc
13/11/202321:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CARACara Therapeutics Inc
13/11/202321:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CARACara Therapeutics Inc
13/11/202321:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CARACara Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CARA

Your Recent History

LSE
BOO
Boohoo
LSE
POS
Plexus
LSE
CHLL
Chill Brands
LSE
AAZ
Anglo Asian Mining
LSE
RR.
Rolls-royce
LSE
VAST
Vast Resources
LSE
CSFS
Cornerstone Fs
LSE
AGL
Angle
LSE
GCM
Gcm Resources
LSE
APH
Alliance Pharma
LSE
PET
Petrel Resources
LSE
BARC
Barclays
LSE
KEFI
Kefi Gold And Copper
LSE
TERN
Tern
LSE
SYME
Supply@me Capital
LSE
GKP
Gulf Keystone Petroleum
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved